• Search
  • Advanced Search

Review Article

February 28, 2025


Efficacy of Bisphosphonate in Patients with Neurofibromatosis Type 1
Arzu Jalilova, Alessandra Cocca
J Bone Metab. 2025;32(1):1-10.

This review aims to synthesize current knowledge regarding the use of bisphosphonates (BPs) in the treatment of bone complications in patients with neurofibromatosis type 1 (NF1). NF1 is a genetic...

Original Article

February 28, 2025


Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin Pathway
Mahsa Tahoori, Azita Parvaneh Tafreshi, Fatemeh Naghshnejad, et al.
J Bone Metab. 2025;32(1):11-20.

Background: Due to the contradictory and temporally variable effects of transforming growth factor-β (TGF-β) and the Wnt/β-catenin pathways on osteogenic differentiation in different stem cell types, we sought to examine...

Original Article

February 28, 2025


Pharmacogenetics of Response to Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Prospective Study
Sirin Akbulut Ayturk, Ozden Ozyemisci Taskiran, Ebru Koseoglu Tohma, et al.
J Bone Metab. 2025;32(1):21-30.

Background: This study aims to investigate the effect of genetic polymorphisms of vitamin D receptor (VDR), estrogen receptor 1 (ER1), and Col1a1 on the response to bisphosphonate (BP) therapy in...

Original Article

February 28, 2025


Generate Quantitative Computed Tomography-Equivalent Computed Tomography Image Interpretation Reports in Patients with Spinal Deformities
Hyunbin Kim, Hyeon Su Kim, Shinjune Kim, et al.
J Bone Metab. 2025;32(1):31-37.

Background: Quantitative computed tomography (QCT) is essential for assessing osteoporosis and monitoring spinal deformities. “Clari-QCT,” a software that uses artificial intelligence to analyze conventional computed tomography (CT) scans and produce...

Original Article

February 28, 2025


Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study
Marta Villanova, Sharon H. Chou, Le Min
J Bone Metab. 2025;32(1):38-48.

Background: Bone-target agents (BTAs), including denosumab (DMAb), are one of the bone metastasis treatments that should continue indefinitely. However, BTAs may be interrupted in some cases. In osteoporosis, DMAb withdrawal...

Original Article

February 28, 2025


Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis
Takeshi Mochizuki, Mari Ando, Koichiro Yano, et al.
J Bone Metab. 2025;32(1):49-56.

Background: Patients with rheumatoid arthritis (RA) are at an increased risk of osteoporosis and vertebral fractures. This study aimed to investigate factors associated with vertebral fractures and treatment goals to...

Original Article

February 28, 2025


Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, et al.
J Bone Metab. 2025;32(1):57-66.

Background: Osteoporosis is a significant public health issue in aging populations. Despite advances in pharmacotherapy, underdiagnosis and undertreatment remain prevalent even in patients with recent fractures. This study examined 20-year...

Letter to the Editor

February 28, 2025


Calcium Supplementation: To Do or Not to Do
Emanuella Graciela Borges Fonseca, Carlos Marques dos Santos, Felipe Freire da Silva, et al.
J Bone Metab. 2025;32(1):67-68.
Current Issue
Volume 32(1); Feb 2025
Review Article
740
Efficacy of Bisphosphonate in Patients with Neurofibromatosis Type 1
Arzu Jalilova, Alessandra Cocca
J Bone Metab. 2025;32(1):1-10.   Published online February 28, 2025
View: 1041   Download: 44
Original Article
741
Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin Pathway
Mahsa Tahoori, Azita Parvaneh Tafreshi, Fatemeh Naghshnejad, Bahman Zeynali
J Bone Metab. 2025;32(1):11-20.   Published online February 28, 2025
View: 917   Download: 35  Citation: 1
742
Pharmacogenetics of Response to Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Prospective Study
Sirin Akbulut Ayturk, Ozden Ozyemisci Taskiran, Ebru Koseoglu Tohma, Aylin Sepici Dincel, Nesrin Demirsoy, Vesile Sepici
J Bone Metab. 2025;32(1):21-30.   Published online February 28, 2025
View: 771   Download: 39
743
Generate Quantitative Computed Tomography-Equivalent Computed Tomography Image Interpretation Reports in Patients with Spinal Deformities
Hyunbin Kim, Hyeon Su Kim, Shinjune Kim, Jun-Il Yoo
J Bone Metab. 2025;32(1):31-37.   Published online February 28, 2025
View: 673   Download: 19
744
Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study
Marta Villanova, Sharon H. Chou, Le Min
J Bone Metab. 2025;32(1):38-48.   Published online February 28, 2025
View: 889   Download: 38
745
Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis
Takeshi Mochizuki, Mari Ando, Koichiro Yano, Ryo Hiroshima, Katsunori Ikari, Ken Okazaki
J Bone Metab. 2025;32(1):49-56.   Published online February 28, 2025
View: 792   Download: 28
746
Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, Jihye Kim, Hoyeon Jang, Jaiyong Kim, Ha Young Kim
J Bone Metab. 2025;32(1):57-66.   Published online February 28, 2025
View: 1001   Download: 68
Letter to the Editor
Calcium Supplementation: To Do or Not to Do
Emanuella Graciela Borges Fonseca, Carlos Marques dos Santos, Felipe Freire da Silva, Ana Tereza Amoedo Martinez, Jozélio Freire de Carvalho
J Bone Metab. 2025;32(1):67-68.   Published online February 28, 2025
View: 576   Download: 26

Journal of Bone
Metabolism

Print ISSN: 2287-6375
Online ISSN: 2287-7029

ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Hyundai Kirim Officetel, 42 Seocho-daero 78-gil, Seocho-gu, Seoul 06626, Korea
Tel: +82-2-3473-2231    Fax: +82-70-4156-2230    E-mail: jbm@ksbmr.org                

Copyright © 2025 by The Korean Society for Bone and Mineral Research.

Developed in M2PI

Close layer
prev next